Singapore's Temasek invests in Sun Pharmaceutical

Singapore government-controlled investment group Temasek is not deterred by the experience of Daiichi Sankyo and Ranbaxy Laboratories. It has invested more than half a million dollars in Ranbaxy buyer Sun Pharmaceutical as well as other Indian drugmakers. More from FiercePharmaAsia

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.